<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Shuttle Pharmaceuticals Holdings Inc (SHPH)</title>
    <description>Latest news, press releases, and SEC filings for Shuttle Pharmaceuticals Holdings Inc (SHPH)</description>
    <link>https://caymanjournal.com/stock/SHPH</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 00:03:40 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/SHPH/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>ARS — Shuttle Pharmaceuticals Holdings, Inc.</title>
      <description># ❓ What This Document Is
This document was intended to be an SEC filing for Shuttle Pharmaceuticals Holdings, Inc., specifically an ARS (Amendment to Report). An ARS is typically used when the company needs to formally correct or update information that was presented in a previous filing. Essential</description>
      <link>https://caymanjournal.com/stock/SHPH/sec-filing/0001493152-26-018120</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SHPH/sec-filing/0001493152-26-018120</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>DEF 14A — Shuttle Pharmaceuticals Holdings, Inc.</title>
      <description># 📄 What This Document Is 📜
This is a Definitive Proxy Statement (Form DEF 14A) for Shuttle Pharmaceuticals Holdings, Inc. It&apos;s essentially a detailed packet of documents that comes to shareholders before an Annual Meeting. Its primary purpose is to educate shareholders on who the company is, who </description>
      <link>https://caymanjournal.com/stock/SHPH/sec-filing/0001493152-26-018117</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SHPH/sec-filing/0001493152-26-018117</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>PRE 14A — Shuttle Pharmaceuticals Holdings, Inc.</title>
      <description># 📄 What This Document Is
This is a **PRE 14A**, a *preliminary proxy statement*. It&apos;s a formal document sent to shareholders ahead of a company&apos;s annual meeting. Its job is to explain what will be voted on and provide the information shareholders need to make informed decisions.

👉 **Why it matte</description>
      <link>https://caymanjournal.com/stock/SHPH/sec-filing/0001493152-26-016212</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SHPH/sec-filing/0001493152-26-016212</guid>
      <pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>